Status:
COMPLETED
Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)
Lead Sponsor:
Seoul National University Hospital
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The purpose of this study is to choose the preferred treatment modality for solitary, small hepatocellular carcinoma.
Detailed Description
To compare the below things between operation group and percutaneous ethanol injection therapy (PEIT) group: 1. Survival * 5 year overall survival rate * Disease free survival rate 2. Recurren...
Eligibility Criteria
Inclusion
- The evidences of hepatitis B virus (HBV)\&/or hepatitis C virus (HCV) infection or liver cirrhosis
- Single tumor nodule with Child-Pugh classification A (serum albumin ≥ 3.2 g/dL)
- The maximal, longest diameter of tumor mass measured by CT finding should be less than 2 cm
- Only for the newly detected HCCs which were not treated before
- It should be compatible with the typical finding of hepatocellular carcinomas (HCCs) radiologically (MD CT or dynamic MRI)
- Without portal hypertension
Exclusion
- In case of hepatic vein or portal vein invasion radiologically (CT or MRI)
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00357422
Start Date
October 1 2005
End Date
July 1 2011
Last Update
September 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul NUH
Seoul, Chongno-gu, South Korea, 110-744